ENLV Enlivex Therapeutics Ltd.

Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

$7.44
As of 07/23/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  11/02/2017
Outstanding shares:  15,759,878
Average volume:  59,517
Market cap:   $121,193,462
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    
ISIN:        
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.29
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%